Cite
HARVARD Citation
Speigl, L. et al. (2017). Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma. British journal of dermatology. pp. 1447-1449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Speigl, L. et al. (2017). Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma. British journal of dermatology. pp. 1447-1449. [Online].